Processing of CFTR: Traversing the cellular maze—How much CFTR needs to go through to avoid cystic fibrosis?
- 11 March 2005
- journal article
- review article
- Published by Wiley in Pediatric Pulmonology
- Vol. 39 (6) , 479-491
- https://doi.org/10.1002/ppul.20168
Abstract
Biosynthesis of the cystic fibrosis transmembrane conductance regulator (CFTR), like other proteins aimed at the cell surface, involves transport through a series of membranous compartments, the first of which is the endoplasmic reticulum (ER), where CFTR encounters the appropriate environment for folding, oligomerization, maturation, and export from the ER. After exiting the ER, CFTR has to traffic through complex pathways until it reaches the cell surface. Although not yet fully understood, the fine details of these pathways are starting to emerge, partially through identification of an increasing number of CFTR‐interacting proteins (CIPs) and the clarification of their roles in CFTR trafficking and function. These aspects of CFTR biogenesis/degradation and by membrane traffic and CIPs are discussed in this review. Following this description of complex pathways and multiple checkpoints to which CFTR is subjected in the cell, the basic question remains of how much CFTR has to overcome these barriers and be functionally expressed at the plasma membrane to avoid CF. This question is also discussed here. Pediatr Pulmonol.Keywords
Funding Information
- FCT, Portugal (POCTI/MGI/35737/2000, POCTI/MGI/47382/2002)
- FEDER, European Union
This publication has 100 references indexed in Scilit:
- Syntaxin 8 impairs trafficking of cystic fibrosis transmembrane conductance regulator (CFTR) and inhibits its channel activityJournal of Cell Science, 2004
- High frequency of T9 and CFTR mutations in children with idiopathic bronchiectasisJournal of Medical Genetics, 2003
- Traffic-independent function of the Sar1p/COPII machinery in proteasomal sorting of the cystic fibrosis transmembrane conductance regulatorThe Journal of cell biology, 2003
- PDZ Domain Interaction Controls the Endocytic Recycling of the Cystic Fibrosis Transmembrane Conductance RegulatorJournal of Biological Chemistry, 2002
- Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implicationsBiochemical Journal, 2002
- A protein sequence that can encode native structure by disfavoring alternate conformationsNature Structural & Molecular Biology, 2002
- Use of protein repair therapy in the treatment of cystic fibrosisCurrent Opinion in Pediatrics, 1998
- Complexity in a monogenic diseaseNature Genetics, 1996
- Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis MutationJournal of Biological Chemistry, 1996
- Cystic fibrosis: molecular biology and therapeutic implicationsScience, 1992